ID KMOE-2 AC CVCL_1332 SY KMOE2; Kmoe2 DR CLO; CLO_0007114 DR CLDB; cl3034 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-3610 DR BioSample; SAMN03473322 DR cancercelllines; CVCL_1332 DR Cell_Model_Passport; SIDM01019 DR ChEMBL-Cells; CHEMBL3308236 DR ChEMBL-Targets; CHEMBL2366347 DR Cosmic; 787445 DR Cosmic; 907280 DR Cosmic; 975262 DR Cosmic; 1012079 DR Cosmic; 1465969 DR Cosmic; 2131542 DR Cosmic; 2306213 DR Cosmic-CLP; 907280 DR DepMap; ACH-002258 DR DSMZ; ACC-37 DR DSMZCellDive; ACC-37 DR EGA; EGAS00001000978 DR GDSC; 907280 DR GEO; GSM1446748 DR GEO; GSM1669991 DR IARC_TP53; 21434 DR LINCS_LDP; LCL-1058 DR PharmacoDB; KMOE2_757_2019 DR PRIDE; PXD030304 DR PubChem_Cell_line; CVCL_1332 DR Wikidata; Q54900132 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=6949905; RX PubMed=16408098; RX PubMed=20164919; RX PubMed=27397505; RX PubMed=30894373; RX PubMed=35839778; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Population: Japanese. CC Doubling time: 24.2 hours (PubMed=6949905); ~40-50 hours (DSMZ=ACC-37). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (Cosmic-CLP=907280; DepMap=ACH-002258). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Homozygous (Cosmic-CLP=907280; DepMap=ACH-002258). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0.41%; Native American=0.02%; East Asian, North=78.12%; East Asian, South=19.8%; South Asian=1.43%; European, North=0.23%; European, South=0% (PubMed=30894373). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. ST Source(s): Cosmic-CLP=907280; DSMZ=ACC-37 ST Amelogenin: X ST CSF1PO: 9,12 ST D13S317: 8,11 ST D16S539: 9,11 ST D18S51: 18,22 ST D19S433: 13,16 ST D21S11: 28,29 ST D2S1338: 20,25 ST D3S1358: 15,16 ST D5S818: 8,10 ST D7S820: 10 ST D8S1179: 13,16 ST FGA: 19,22 ST Penta D: 11,12 ST Penta E: 11,12 ST TH01: 6,9 ST TPOX: 9 ST vWA: 14,17 DI NCIt; C7152; Erythroleukemia DI ORDO; Orphanet_318; Acute erythroid leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_W022 ! KMOE-1 SX Female AG 2Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 41 CH CVCL_UF71 ! KMOE-2/05 // RX PubMed=16408098; DOI=10.1038/sj.leu.2404081; RA Quentmeier, Hilmar RA MacLeod, Roderick A.F. RA Zaborski, Margarete RA Drexler, Hans Gunther RT "JAK2 V617F tyrosine kinase mutation in cell lines derived from RT myeloproliferative disorders."; RL Leukemia 20:471-476(2006). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=6949905; DOI=10.1007/BF00410534; RA Okano, Hiromitsu RA Okamura, Jun RA Yagawa, Katsuro RA Tasaka, Hideko RA Motomura, Seiji RT "Human erythroid cell lines derived from a patient with acute RT erythremia."; RL J. Cancer Res. Clin. Oncol. 102:49-55(1981). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). //